Play Earnings CallPlay Earnings Call
Ulta Beauty, Inc. (ULTA) Q3 2026 Earnings Call December 4, 2025 4:30 PM EST
Company Participants
Kiley Rawlins – Vice President of Investor Relations
Kecia Steelman – President, CEO & Director
Chris Lialios – Senior VP, Interim CFO & Controller
Conference Call Participants
Lorraine Maikis – BofA Securities, Research Division
Steven Forbes – Guggenheim Securities, LLC, Research Division
Anthony Chukumba – Loop Capital Markets LLC, Research Division
Anna Andreeva – Piper Sandler & Co., Research Division
Rupesh Parikh – Oppenheimer & Co. Inc., Research Division
Kelly Crago – Citigroup Inc., Research Division
Michael Lasser – UBS Investment Bank, Research Division
Irwin Boruchow – Wells Fargo Securities, LLC, Research Division
Michael Baker – D.A. Davidson & Co., Research Division
Dana Telsey – Telsey Advisory Group LLC
Michael Binetti – Evercore ISI Institutional Equities, Research Division
Adrienne Yih-Tennant – Barclays Bank PLC, Research Division
Simeon Gutman – Morgan Stanley, Research Division
Olivia Tong Cheang – Raymond James & Associates, Inc., Research Division
Presentation
Operator
Good afternoon, everyone. My name is Leila, and I will be your conference operator today. At this time, I would like to welcome you to Ulta Beauty’s Third Quarter 2025 Earnings Call. This conference is being recorded. [Operator Instructions] At this time, I would like to turn the call over to Ms. Kiley Rawlins, Senior Vice President, Investor Relations. Ms. Rawlins, please proceed.
Kiley Rawlins
Vice President of Investor Relations
Thank you, Leila. Good afternoon, everyone, and thank you for joining us for a discussion of Ulta Beauty’s results for the third quarter of fiscal 2025. Hosting our call today are Kecia Steelman, President and Chief Executive Officer; and Chris Lialios, Interim Chief Financial Officer. As a reminder, today’s earnings release and the comments made by management during this call include forward-looking statements.
These statements are subject to risks and uncertainties that could cause our actual results to differ materially from
